Gates Foundation

8.

Independent research in Eastern and Southern Africa identifies opportunities to improve effectiveness of Global Fund processes

10 Dec 2018
'Synthesis report' focuses on grants in Malawi, Tanzania and Zimbabwe
3.

Global Fund to benefit from “breakthrough” ARV pricing agreement

3 Oct 2017
State-of-the-art fixed dose combination regimen will cost $75 per patient per year

In what has been hailed as a “breakthrough” and a “game changer,” a pricing agreement between the Bill and Melinda Gates Foundation and two generic drug companies will result in significant savings in the cost of antiretrovirals (ARVs). As a result of the agreement, starting in 2018 a state-of-the-art fixed dose combination ARV regimen will be available in 92 developing nations at a maximum cost of $75 per patient per year.

2.

Financial Developments

16 Jul 2004
  • The Bill and Melinda Gates Foundation yesterday announced a new pledge of $50 million for the Fund. This marks the third consecutive year in which Gates has given $50 million to the Fund. Although private foundations have a Global Fund board seat, no other foundation has ever given to the Fund, except for pro bono services and some very minor donations of a few thousand dollars.
Подписка на Gates Foundation